Search results
This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.
- Effective drugs used to combat SARS-CoV-2 infection and the current ...
As well as one of the most promising medications currently...
- Effective drugs used to combat SARS-CoV-2 infection and the current ...
19 kwi 2023 · Once severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is diagnosed, anti-SARS-CoV-2 therapies are ideally administered to outpatients as soon as possible so that the...
15 kwi 2024 · The SARS-CoV-2 replication cycle and potential therapeutic targets. Various steps in the SARS-CoV-2 replication cycle (Fig. 3) involving viral components (see Supplementary Table 1)...
As well as one of the most promising medications currently effective against SARS-CoV-2 is Favipiravir, an inhibitor of RNA-dependent polymerase (RdRp) prescribed to Ebola virus-infected patients, authorized for evolving influenza in Japan and SARS-CoV-2 therapy in China [, , ].
26 sie 2021 · SARS-CoV-2 infection and immunity dysfunction are the two main courses driving the pathogenesis of COVID-19. Both the virus and host factors are potential targets for antiviral therapy.
27 paź 2021 · Highly effective therapeutic agents directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19, are needed for these high-risk persons.
5 lip 2022 · Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely used in the ongoing COVID-19 pandemic.
